"I Already Use Another Brand"
This is the most common objection a representative will hear, and the weakest response is criticizing the competing brand directly, which tends to read as defensive rather than confident. A stronger approach asks a genuinely curious question, what does that brand demonstrate in terms of certification or consistency, then offers a specific, factual contrast, this formulation is manufactured under WHO-GMP certification with batch testing before dispatch, without disparaging the alternative directly. This keeps the conversation grounded in verifiable facts rather than becoming a comparative argument the doctor didn't ask for.
"I Haven't Seen Any Data on This"
This objection is really a request for evidence, and it should be treated as one rather than deflected with reassurance. The right response leads directly with whatever specific evidence exists, DCGI approval status, formulation rationale, or where relevant, the broader pharmacological research behind key ingredients, covered in more depth in Cafoli's Ayurvedic product range backed by science for herbal formulations specifically. A doctor asking this question is genuinely evaluable, giving them nothing beyond "it works well" wastes a real opportunity to earn their consideration.
"This Is More Expensive Than What I'm Using"
Price objections are best handled by reframing quality as the actual driver of price rather than apologizing for it. Instead of discounting or deflecting, the stronger response connects the price directly to what it protects, consistent manufacturing, verified certification, and formulation reliability, a doctor's own patients and reputation depend on. This exact reframe is covered in affordable price, branded quality: a general range strategy, which treats price justification as a matter of connecting cost to consistency rather than treating price itself as something to be negotiated down.
Silence or a Noncommittal Response
A doctor who simply nods without genuine engagement is often not rejecting the pitch outright, but hasn't yet found a reason to engage with it seriously. Rather than repeating the same pitch louder or faster, a better response asks a specific, open-ended question, what would be most useful to know about this formulation, or what's typically the deciding factor when trying something new, which shifts the conversation from a monologue back into a genuine exchange the doctor has some stake in.
Skepticism About an Unfamiliar or Newer Company
When the objection is really about the company itself rather than the specific product, generic reassurance about being trustworthy accomplishes little. Leveraging concrete, verifiable track record, why the company is trusted by a large existing base of franchise partners, or genuine testimonials from other partners, gives a doctor social proof grounded in something real rather than a representative's own self-assessment.